Publications by authors named "Stephane St-Onge"

Claim this Profile
M
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction.
John Lupisella, Stéphane St-Onge, Marilyn Carrier, Erica M Cook, Tao Wang

ACS Pharmacol Transl Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.
Charlotte Avet, Arturo Mancini, Billy Breton, Christian Le Gouill, Alexander S Hauser, Stéphane St-Onge

Elife· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction.
Ricardo A García, John A Lupisella, Bruce R Ito, Mei-Yin Hsu, Gayani Fernando, Stéphane St-Onge

JACC Basic Transl Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Peter Gargalovic, Pancras Wong, Joelle Onorato, Heather Finlay, Tao Wang, Stéphane St-Onge

Circ Heart Fail· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment.
Ricardo A García, Bruce R Ito, John A Lupisella, Nancy A Carson, Mei-Yin Hsu, Stéphane St-Onge

JACC Basic Transl Sci· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of agonists of cannabinoid receptor 1 with restricted central nervous system penetration aimed for treatment of gastroesophageal reflux disease.
Alleyn T Plowright, Karolina Nilsson, Madeleine Antonsson, Kosrat Amin, Johan Broddefalk, Stephane St-Onge

J Med Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration.
Zhongyong Wei, Hua Yang, Ziping Liu, Maxime Tremblay, Shawn Johnstone, Stéphane St-Onge

Bioorg Med Chem Lett· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γ-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.
Yun-Xing Cheng, Mehrnaz Pourashraf, Xuehong Luo, Sanjay Srivastava, Christopher Walpole, Stephane St-Onge

Bioorg Med Chem Lett· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.
Xiao Hong Yu, Chang Qing Cao, Giovanni Martino, Carole Puma, Anne Morinville, Stéphane St-Onge

Pain· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models.
Paul Jones, Andrew M Griffin, Lars Gawell, Rico Lavoie, Daniel Delorme, Stephane St-Onge

Bioorg Med Chem Lett· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel benzimidazole derivatives as selective CB2 agonists.
Daniel Pagé, Elise Balaux, Luc Boisvert, Ziping Liu, Claire Milburn, Stéphane St-Onge

Bioorg Med Chem Lett· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists.
Daniel Pagé, Hua Yang, William Brown, Christopher Walpole, Manon Fleurent, Stéphane St-Onge

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis